SR
Sunita Rani
About Sunita Rani
Data last updated:
Sunita Rani is a Director at Stafford Laboratories Private Limited (since 2020), Director at Life Line Remedies (India) Private Limited (since 2020) and Director at Ersten Life Science Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹36.69 Cr; the largest is Stafford Laboratories Private Limited at ₹33.42 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stafford Laboratories Private Limited U24232WB1999PTC089423 | Director | 03 Aug 2020 | 1999 | ₹33.42 Cr (FY 2024) | Active |
_PRIVATE_LIMITED_355366.webp){kind=small} Life Line Remedies (India) Private Limited U74899DL1999PTC101601 | Director | 03 Aug 2020 | 1999 | ₹3.27 Cr (FY 2025) | Active |
 Ersten Life Science Private Limited U24231DL2002PTC117106 | Director | 21 Apr 2022 | 2002 | Active |
Board colleagues of Sunita Rani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Debi Datta | 00889056 | Stafford Laboratories Private Limited | Director |
| Prasanta Datta | 02596520 | Stafford Laboratories Private Limited | Director |
| Raj Kumar | 01376777 | Stafford Laboratories Private Limited , Life Line Remedies (India) Private Limited and 1 more | Director |
| Prem Nath Juneja | 00573578 | Life Line Remedies (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunita Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunita Rani
Sunita Rani currently holds 3 directorships: Stafford Laboratories Private Limited (Director, since 03 Aug 2020, revenue ₹33.42 Cr (FY 2024)); Life Line Remedies (India) Private Limited (Director, since 03 Aug 2020, revenue ₹3.27 Cr (FY 2025)); Ersten Life Science Private Limited (Director, since 21 Apr 2022).
Sunita Rani was first appointed on 03 Aug 2020 as Director at Stafford Laboratories Private Limited. The most recent appointment on record is 21 Apr 2022 at Ersten Life Science Private Limited.
The 2 current companies of Sunita Rani that report revenue have a combined latest revenue of ₹36.69 Cr: Stafford Laboratories Private Limited ₹33.42 Cr (FY 2024); Life Line Remedies (India) Private Limited ₹3.27 Cr (FY 2025).
The current boards of Sunita Rani's companies include Debi Datta (Stafford Laboratories Private Limited), Prasanta Datta (Stafford Laboratories Private Limited), Raj Kumar (Stafford Laboratories Private Limited), Prem Nath Juneja (Life Line Remedies (India) Private Limited).